Search for: "Bayer Schering Pharma AG"
Results 1 - 20
of 45
Sort by Relevance
|
Sort by Date
6 May 2017, 10:11 am
”Bayer Schering Pharma AG v. [read post]
5 Mar 2014, 2:46 pm
Bayer Corp., U.S. [read post]
25 Feb 2014, 2:49 pm
The German Schering AG was Berlex, Inc. in North America while Schering-Plough was Essex Pharma GmbH in Germany, Austria and Switzerland. [read post]
19 Sep 2013, 9:53 am
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
26 Apr 2012, 1:00 am
In Bayer Schering Pharma AG v. [read post]
18 Apr 2012, 9:12 pm
By Andrew Williams -- In a second case involving the Hatch-Waxman regulatory scheme decided by the Federal Circuit on Monday, the Court held in Bayer Schering Pharma AG v. [read post]
12 Mar 2012, 3:55 am
Gedeon Richter plc v Bayer Schering Pharma AG [2012] EWCA Civ 235; [2012] WLR (D) 66 “On an application for the revocation of a registered patent on the ground of obviousness it was sufficient for the judge hearing the case to take an objective view whether a skilled formulator would take the trouble to obtain copies of papers published by inventors or review their contents to ascertain whether the patent in question related to an invention which was novel. [read post]
22 Feb 2012, 5:49 pm
” Depending on who you ask, Bayer Schering Pharma AG v. [read post]
3 Oct 2011, 5:20 am
Having briefly summarised Ranbaxy v AstraZeneca, Datacard Corporation v Eagle and Gedeon Richter v Bayer Schering Pharma AG, Mr Alexander stressed that the prior art status of commonly accessible documents marked confidential in LG Electronics v Sony was yet to be conclusively determined – "watch this space". [read post]
25 Aug 2011, 8:14 am
Bayer Schering., 575 F.3d at 1347. [read post]
25 Aug 2011, 8:14 am
Bayer Schering., 575 F.3d at 1347. [read post]
19 Apr 2011, 5:04 pm
Infosint (IPKat) (PatLit) Clobex (Clobetasol) – US: Galderma, Dermalogix agree to end Clobex suit with Paddock (Patent Docs) Crestor (Rosuvastatin) – US: Palmetto files patent infringement suit against AstraZeneca based on its Crestor product; AstraZeneca files for declaratory judgment of non-infringement and invalidity (Patent Docs) Drospirenone, Ethinylestradiol – UK: Shedding further light on obviousness: Gedeon Richter PC v Bayer Schering Pharma… [read post]
29 Mar 2011, 9:19 pm
(The IP Factor) Products Actonel (Risedronate) – US: Warner Chilcott files patent infringement complaint against Mylan in response to Para IV certification (Patent Docs) Actos (Pioglitazone) – US: Takeda files patent infringement suit against Apotex following Para IV challenge (Patent Docs) Antara (Fenofibrate) – US: Lupin files patent infringement lawsuits against Mylan, Apotex following Para IV certification (Patent Docs) Drospirenone, Ethinylestradiol – EU: Inventive step,… [read post]
18 Mar 2011, 4:31 am
Court of Appeal (Civil Division) M v F & Ors [2011] EWCA Civ 273 (17 March 2011) High Court (Administrative Court) Johnson , Re [2011] EWHC 593 (Admin) (17 March 2011) Q, R (on the application of) v Q Constabulary & Anor [2011] EWHC 592 (Admin) (17 March 2011) Hinds, R (on the application of) v Blackpool Council [2011] EWHC 591 (Admin) (17 March 2011) High Court (Chancery Division) The Lorenz Consultancy Ltd. v Fox-Davies Capital Ltd. [2011] EWHC 574 (Ch) (17 March 2011) Carey Group Plc… [read post]
13 Mar 2011, 1:50 pm
., Bayer Schering Pharma AG v. [read post]
9 Mar 2011, 3:00 am
Bayer AG (FDA Law Blog) (Patent Docs) Melatonin – EWCA refers SPC questions to the ECJ: Neurim Pharmaceuticals (1991) Ltd v Comptroller General of Patents (The SPC Blog) (The SPC Blog) (EPLAW) (IPKat) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
8 Jan 2011, 2:18 pm
IN/PCT/2002/410/CHE filed by Bayer Schering Pharma, AG claiming contraceptive formulation of drospirenone and ethinylestradiol (EE) marketed as Yasmin and Yaz/Yasminelle in Europe and the US. [read post]
8 Jan 2011, 2:18 pm
IN/PCT/2002/410/CHE filed by Bayer Schering Pharma, AG claiming contraceptive formulation of drospirenone and ethinylestradiol (EE) marketed as Yasmin and Yaz/Yasminelle in Europe and the US. [read post]
6 Oct 2010, 4:22 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
30 Sep 2010, 8:19 am
" Bayer Schering Pharma AG et al v. [read post]
